NuCana plc American Depositary Share
NCNA
NCNA: NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.
moreShow NCNA Financials
Recent trades of NCNA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NCNA's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on NCNA's company Twitter account
Number of mentions of NCNA in WallStreetBets Daily Discussion
Recent insights relating to NCNA
Recent picks made for NCNA stock on CNBC
ETFs with the largest estimated holdings in NCNA
Flights by private jets registered to NCNA